Bioinformatics Analysis of miRNA Sequencing Data von Lokhande, Hrishikesh A.

Volltext

A probiotic modulates the microbiome and immunity in multiple sclerosis von Tankou, Stephanie K., Regev, Keren, Healy, Brian C., Tjon, Emily, Laghi, Luca, Cox, Laura M., Kivisäkk, Pia, Pierre, Isabelle V., Hrishikesh, Lokhande, Gandhi, Roopali, Cook, Sandra, Glanz, Bonnie, Stankiewicz, James, Weiner, Howard L.

Volltext

Early Predictors of Clinical and MRI Outcomes Using Least Absolute Shrinkage and Selection Operator (LASSO) in Multiple Sclerosis von Bose, Gauruv, Healy, Brian C., Lokhande, Hrishikesh A., Sotiropoulos, Marinos G., Polgar‐Turcsanyi, Mariann, Anderson, Mark, Glanz, Bonnie I., Guttman, Charles R. G., Bakshi, Rohit, Weiner, Howard L., Chitnis, Tanuja

Volltext

Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases von Saxena, Shrishti, Lokhande, Hrishikesh, Gombolay, Grace, Raheja, Radhika, Rooney, Timothy, Chitnis, Tanuja

Volltext

Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis von Bose, Gauruv, Healy, Brian C, Barro, Christian, Moreira Ferreira, Vanessa F, Saxena, Shrishti, Glanz, Bonnie I, Lokhande, Hrishikesh A, Polgar-Turcsanyi, Mariann, Bakshi, Rohit, Weiner, Howard L, Chitnis, Tanuja

Volltext

Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study von Zhao, Yijun, Wang, Tong, Bove, Riley, Cree, Bruce, Henry, Roland, Lokhande, Hrishikesh, Polgar-Turcsanyi, Mariann, Anderson, Mark, Bakshi, Rohit, Weiner, Howard L., Chitnis, Tanuja

Volltext

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis von Chitnis, Tanuja, Qureshi, Ferhan, Gehman, Victor M., Becich, Michael, Bove, Riley, Cree, Bruce A. C., Gomez, Refujia, Hauser, Stephen L., Henry, Roland G., Katrib, Amal, Lokhande, Hrishikesh, Paul, Anu, Caillier, Stacy J., Santaniello, Adam, Sattarnezhad, Neda, Saxena, Shrishti, Weiner, Howard, Yano, Hajime, Baranzini, Sergio E.

Volltext

Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study von Gonzalez-Martinez, Alicia, Bose, Gauruv, Lokhande, Hrishikesh, Saxena, Shrishti, Healy, Brian C, Polgar-Turcsanyi, Mariann, Weiner, Howard L, Chitnis, Tanuja

Volltext

Dissection of multiple sclerosis genetics identifies B and CD4+ T cells as driver cell subsets von Guo, Michael H, Sama, Prashanth, LaBarre, Brenna A, Lokhande, Hrishikesh, Balibalos, John, Chu, Ci, Du, Xiaomi, Kheradpour, Pouya, Kim, Charles C, Oniskey, Taylor, Snyder, Thomas, Soghoian, Damien Z, Weiner, Howard L, Chitnis, Tanuja, Patsopoulos, Nikolaos A

Volltext

miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod von Gonzalez-Martinez, Alicia, Patel, Rohit, Healy, Brian C, Lokhande, Hrishikesh, Paul, Anu, Saxena, Shrishti, Polgar-Turcsanyi, Mariann, Weiner, Howard L, Chitnis, Tanuja

Volltext

Key epigenetic and signaling factors in the formation and maintenance of the blood-brain barrier von Sadanandan, Jayanarayanan, Thomas, Sithara, Mathew, Iny Elizabeth, Huang, Zhen, Blackburn, Spiros L, Tandon, Nitin, Lokhande, Hrishikesh, McCrea, Pierre D, Bresnick, Emery H, Dash, Pramod K, McBride, Devin W, Harmanci, Arif, Ahirwar, Lalit K, Jose, Dania, Dienel, Ari C, Zeineddine, Hussein A, Hong, Sungha, Kumar T, Peeyush

Volltext

Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes von Bose, Gauruv, Healy, Brian C., Saxena, Shrishti, Saleh, Fermisk, Paul, Anu, Barro, Christian, Lokhande, Hrishikesh A., Polgar-Turcsanyi, Mariann, Anderson, Mark, Glanz, Bonnie I., Guttmann, Charles R.G., Bakshi, Rohit, Weiner, Howard L., Chitnis, Tanuja

Volltext

Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects von Chitnis, Tanuja, Kaskow, Belinda J, Case, Junning, Hanus, Katherine, Li, Zhenhua, Varghese, Johnna F, Healy, Brian C, Gauthier, Christian, Saraceno, Taylor J, Saxena, Shrishti, Lokhande, Hrishikesh, Moreira, Thais G, Zurawski, Jonathan, Roditi, Rachel E, Bergmark, Regan W, Giovannoni, Federico, Torti, Maria F, Li, Zhaorong, Quintana, Francisco, Clementi, William A, Shailubhai, Kunwar, Weiner, Howard L, Baecher-Allan, Clare M

Volltext

Author Correction: Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study von Zhao, Yijun, Wang, Tong, Bove, Riley, Cree, Bruce, Henry, Roland, Lokhande, Hrishikesh, Polgar-Turcsanyi, Mariann, Anderson, Mark, Bakshi, Rohit, Weiner, Howard L., Chitnis, Tanuja

Volltext

Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability von Sotiropoulos, Marinos G, Lokhande, Hrishikesh, Healy, Brian C, Polgar-Turcsanyi, Mariann, Glanz, Bonnie I, Bakshi, Rohit, Weiner, Howard L, Chitnis, Tanuja

Volltext

Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS von Lokhande, Hrishikesh, Rosso, Mattia, Tauhid, Shahamat, Chu, Renxin, Healy, Brian C., Saxena, Shrishti, Barro, Christian, Paul, Anu, Polgar-Turcsanyi, Mariann, Anderson, Mark, Glanz, Bonnie I., Kropshofer, Harald, Granziera, Cristina, Leppert, David, Kappos, Ludwig, Kuhle, Jens, Weiner, Howard L., Bakshi, Rohit, Chitnis, Tanuja

Volltext

Functional analysis of validated miRNAs associated with MS disability (P2-4.005) von Gonzalez-Martinez, Alicia, Lokhande, Hrishikesh, Chitnis, Tanuja

Volltext

NF-κB and STAT3 activation in CD4 T cells in pediatric MOG antibody-associated disease von Corbali, Osman, Saxena, Shrishti, Patel, Rohit, Lokhande, Hrishikesh, Chitnis, Tanuja

Volltext

Younger Age at Multiple Sclerosis Onset Is Associated With Worse Outcomes at Age 50 (P17-4.008) von Bose, Gauruv, Healy, Brian, Glanz, Bonnie, Lokhande, Hrishikesh, Polgar-Turcsanyi, Mariann, Guttmann, Charles, Bakshi, Rohit, Weiner, Howard, Chitnis, Tanuja

Volltext

miRNA as biomarkers of NEDA-3 in multiple sclerosis patients treated with fingolimod, glatiramer acetate and dimethyl-fumarate: Preliminary results (P2-4.004) von Gonzalez-Martinez, Alicia, Healy, Brian C., Lokhande, Hrishikesh, Paul, Anu, Saxena, Shrishti, Polgard-Turcsanyi, Mariann, Weiner, Howard, Chitnis, Tanuja

Volltext